APMAP and Alzheimer disease: Overall, the characterization in this study of the APMAP interactome and the identification of new endogenous modulators of Aβ production not only offer new therapeutic targets for the development of new treatments for neurodegenerative or memory disorders, but they also help to better understand the pathobiological processes of the sporadic, age-related forms of AD.